Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-56,005
Closed -$3.76M 132
2023
Q1
$3.76M Sell
56,005
-73,590
-57% -$5.78M 0.06% 92
2022
Q4
$9.91M Buy
129,595
+157
+0.1% +$11.7K 0.2% 68
2022
Q3
$10.4M Sell
129,438
-88,597
-41% -$8.42M 0.22% 63
2022
Q2
$19.2M Buy
218,035
+49,798
+30% +$5.21M 0.58% 45
2022
Q1
$22.4M Sell
168,237
-345,640
-67% -$43.5M 0.53% 42
2021
Q4
$86.3M Buy
513,877
+16,620
+3% +$2.57M 1.59% 22
2021
Q3
$67.6M Buy
497,257
+361,856
+267% +$46.7M 1.11% 31
2021
Q2
$15.4M Buy
135,401
+1,893
+1% +$183K 0.25% 57
2021
Q1
$11.3M Buy
133,508
+41,451
+45% +$3.46M 0.2% 64
2020
Q4
$7.07M Buy
+92,057
New +$6.22M 0.11% 75

Other funds holding DAVA

Axiom Investors's DAVA Position: Q2 2023 in Review

Axiom Investors sold out of Endava (DAVA) in Q2 2023, closing a stake of 56,005 shares — an estimated $3.76M sold.

Axiom Investors first reported a position in DAVA in Q4 2020 and held it in 10 quarters. The position peaked at $86.3M in Q4 2021. 160 funds tracked by Wall St. Rank hold DAVA as of Q2 2023.

  • Axiom Investors reported no remaining Endava position as of Q2 2023 after selling out during the quarter.
  • Axiom Investors sold 56,005 Endava shares in Q2 2023, an estimated $3.76M.
  • Axiom Investors first reported a position in Endava in Q4 2020 and held it in 10 quarters.
  • Axiom Investors's Endava position peaked at $86.3M in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Endava as of Q2 2023.

Based on Axiom Investors's 13F filing for Q2 2023, filed 10 Aug 2023.